美迪西跌2.02%，成交额1.39亿元，主力资金净流出1539.75万元

Group 1 - The core viewpoint of the articles highlights the recent performance and financial metrics of Medicy, including stock price movements and trading volumes [1][2] - As of September 16, Medicy's stock price decreased by 2.02% to 79.46 CNY per share, with a total market capitalization of 10.676 billion CNY [1] - Year-to-date, Medicy's stock has increased by 163.37%, with notable gains of 19.70% over the last five trading days and 128.66% over the last 60 days [1] Group 2 - Medicy operates in the pharmaceutical and biotechnology sector, specifically in medical research outsourcing, and is involved in various concept sectors including CRO and innovative drugs [2] - For the first half of 2025, Medicy reported a revenue of 540 million CNY, reflecting a year-on-year growth of 3.64%, while the net profit attributable to shareholders was -12.899 million CNY, showing an increase of 81.63% [2] Group 3 - Since its A-share listing, Medicy has distributed a total of 158 million CNY in dividends, with 33.9365 million CNY paid out in the last three years [3]